Skip to main content

Table 2 Serum TIMP-1 and MMP-9 levels at day 1, 4 and 8 of severe MMCAI in 30-day surviving and non-surviving patients

From: High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients

Parameters

Median and percentiles 25th -75th

Survivors

Nonsurvivors

P

Day 1

(n = 34)

(n = 34)

 

TIMP-1 (ng/mL) - median (p 25–75)

206 (173–262)

375 (248–468)

< 0.001

MMP-9 (ng/mL) - median (p 25–75)

839 (719–1192)

708 (396–949)

0.03

Day 4

(n = 34)

(n = 18)

 

TIMP-1 (ng/mL) - median (p 25–75)

208 (193–247)

350 (213–461)

< 0.001

MMP-9 (ng/mL) - median (p 25–75)

596 (408–792)

414 (183–884)

0.13

Day 8

(n = 34)

(n = 12)

 

TIMP-1 (ng/mL) - median (p 25–75)

234 (213–262)

370 (211–451)

0.03

MMP-9 (ng/mL) - median (p 25–75)

370 (295–721)

361 (211–459)

0.61